Several groups have discovered numerous novel FGs, such as those involving ZNF384, MEF2D, PAX5, and DUX4 rearrangements, among cases that were once regarded as B-other-ALL with no defining cytogenetic abnormalities [4–9]. The gene discussed is MEF2D; the disease is acute lymphoblastic leukemia.